BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin SL, Chang HM, Liu CP, Chou LP, Chan JW. Clinical evidence of interaction between clopidogrel and proton pump inhibitors. World J Cardiol 2011; 3(5): 153-164 [PMID: 21666816 DOI: 10.4330/wjc.v3.i5.153]
URL: https://www.wjgnet.com/1949-8462/full/v3/i5/153.htm
Number Citing Articles
1
L-A. Fraser, W. D. Leslie, L. E. Targownik, A. Papaioannou, J. D. Adachi. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis StudyOsteoporosis International 2013; 24(4): 1161 doi: 10.1007/s00198-012-2112-9
2
Nai‐Fang Chi, Chi‐Pang Wen, Chung‐Hsiang Liu, Jie‐Yuan Li, Jiann‐Shing Jeng, Chih‐Hung Chen, Li‐Ming Lien, Ching‐Huang Lin, Yu Sun, Wei‐Lun Chang, Chaur‐Jong Hu, Chung Y. Hsu. Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World DataJournal of the American Heart Association 2018; 7(19) doi: 10.1161/JAHA.118.009856
3
Mizia-Stec Katarzyna, Haberka Maciej, Mizia Magdalena, Lasota Bartosz, Kunecki Marcin, Gieszczyk Klaudia, Chmiel Artur, Najda Jacek, Kyrcz-Krzemień Sławomira, Gąsior Zbigniew. Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary interventionPharmacological Reports 2012; 64(2): 360 doi: 10.1016/S1734-1140(12)70776-4
4
Chuang-Wei Wang, Ivan Arni C. Preclaro, Wei-Hsiang Lin, Wen-Hung Chung. An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: Translation and Implementation of Pharmacogenomic Testing in Clinical PracticeFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.886377
5
Yazhini Rajendran, Yogendra Keche, Nitin R Gaikwad, Suryaprakash Dhaneria. Retrospective Analysis of Potential Adverse Drug Interactions in the Drugs Prescribed to the Elderly at a Tertiary Health Care Center in Raipur, Chhattisgarh, Central IndiaCureus 2024;  doi: 10.7759/cureus.53767